• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性疼痛患者停用完全μ阿片受体激动剂长期阿片类药物治疗后的心理结果变化。

Changes in Psychological Outcomes after Cessation of Full Mu Agonist Long-Term Opioid Therapy for Chronic Pain.

作者信息

Silva Marcelina Jasmine, Coffee Zhanette, Yu Chong Ho Alex, Hu Joshua

机构信息

The Focus on Opioid Transitions (FOOT Steps) Program, IPM Medical Group, Walnut Creek, CA 94598, USA.

College of Nursing, University of Arizona, Tucson, AZ 85721, USA.

出版信息

J Clin Med. 2023 Feb 8;12(4):1354. doi: 10.3390/jcm12041354.

DOI:10.3390/jcm12041354
PMID:36835889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9961404/
Abstract

Improved understanding of psychological features associated with full mu agonist long-term opioid therapy (LTOT) cessation may offer advantages for clinicians. This preliminary study presents changes in psychological outcomes in patients with chronic, non-cancer pain (CNCP) after LTOT cessation via a 10-week multidisciplinary program which included treatment with buprenorphine. Paired -tests pre- and post-LTOT cessation were compared in this retrospective cohort review of data from electronic medical records of 98 patients who successfully ceased LTOT between the dates of October 2017 to December 2019. Indicators of quality of life, depression, catastrophizing, and fear avoidance, as measured by the 36-Item Short Form Survey, the Patient Health Questionnaire-9-Item Scale, the Pain Catastrophizing Scale, and the Fear Avoidance Belief Questionnaires revealed significant improvement. Scores did not significantly improve for daytime sleepiness, generalized anxiety, and kinesiophobia, as measured by the Epworth Sleepiness Scale, the Generalized Anxiety Disorder 7-Item Scale, and the Tampa Scale of Kinesiophobia. The results suggest that successful LTOT cessation may be interconnected with improvements in specific psychological states.

摘要

更好地理解与完全μ激动剂长期阿片类药物治疗(LTOT)戒断相关的心理特征,可能会给临床医生带来好处。这项初步研究展示了慢性非癌性疼痛(CNCP)患者在通过为期10周的多学科项目(包括丁丙诺啡治疗)戒断LTOT后心理结果的变化。在这项回顾性队列研究中,对98例在2017年10月至2019年12月期间成功戒断LTOT的患者的电子病历数据进行了配对t检验,比较了LTOT戒断前后的情况。通过36项简短调查问卷、患者健康问卷9项量表、疼痛灾难化量表和恐惧回避信念问卷测量的生活质量、抑郁、灾难化和恐惧回避指标显示有显著改善。通过爱泼华嗜睡量表、广泛性焦虑障碍7项量表和坦帕运动恐惧量表测量的白天嗜睡、广泛性焦虑和运动恐惧得分没有显著改善。结果表明,成功戒断LTOT可能与特定心理状态的改善相互关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbbb/9961404/7d2bbc601484/jcm-12-01354-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbbb/9961404/501d8413a240/jcm-12-01354-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbbb/9961404/7d2bbc601484/jcm-12-01354-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbbb/9961404/501d8413a240/jcm-12-01354-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbbb/9961404/7d2bbc601484/jcm-12-01354-g002.jpg

相似文献

1
Changes in Psychological Outcomes after Cessation of Full Mu Agonist Long-Term Opioid Therapy for Chronic Pain.慢性疼痛患者停用完全μ阿片受体激动剂长期阿片类药物治疗后的心理结果变化。
J Clin Med. 2023 Feb 8;12(4):1354. doi: 10.3390/jcm12041354.
2
Anxiety and Fear Avoidance Beliefs and Behavior May Be Significant Risk Factors for Chronic Opioid Analgesic Therapy Reliance for Patients with Chronic Pain-Results from a Preliminary Study.焦虑和恐惧回避信念和行为可能是慢性阿片类镇痛药依赖的重要危险因素——一项初步研究的结果。
Pain Med. 2021 Sep 8;22(9):2106-2116. doi: 10.1093/pm/pnab069.
3
Evaluation of Buprenorphine Rotation in Patients Receiving Long-term Opioids for Chronic Pain: A Systematic Review.评估接受长期阿片类药物治疗慢性疼痛患者的丁丙诺啡转换:系统评价。
JAMA Netw Open. 2021 Sep 1;4(9):e2124152. doi: 10.1001/jamanetworkopen.2021.24152.
4
[Long-term opioid therapy of non-cancer pain : Prevalence and predictors of hospitalization in the event of possible misuse].[非癌性疼痛的长期阿片类药物治疗:可能滥用情况下的住院患病率及预测因素]
Schmerz. 2018 Dec;32(6):419-426. doi: 10.1007/s00482-018-0324-4.
5
Long-term opioid therapy of non-cancer pain : Prevalence and predictors of hospitalization in the event of possible misuse.非癌性疼痛的长期阿片类药物治疗:可能滥用情况下住院治疗的患病率及预测因素。
Schmerz. 2020 May;34(Suppl 1):8-15. doi: 10.1007/s00482-018-0331-5.
6
Long-term opioid therapy for chronic non-cancer pain in Germany.德国慢性非癌性疼痛的长期阿片类药物治疗。
Eur J Pain. 2016 May;20(5):767-76. doi: 10.1002/ejp.802. Epub 2015 Oct 22.
7
The best structure of the Tampa Scale for Kinesiophobia for patients with chronic low back pain has two domains and nine items.慢性腰痛患者的 Tampa 运动恐惧量表的最佳结构有两个领域和九个项目。
Clin Rehabil. 2023 Mar;37(3):407-414. doi: 10.1177/02692155221128829. Epub 2022 Sep 21.
8
Efficiency of Associating Therapeutic Patient Education with Rehabilitation in the Management of Chronic Low Back Pain: A Randomized Controlled Trial.慢性下腰痛管理中治疗性患者教育与康复相结合的效果:一项随机对照试验
Korean J Fam Med. 2022 Nov;43(6):367-373. doi: 10.4082/kjfm.21.0223. Epub 2022 Nov 20.
9
Influence of Baseline Kinesiophobia Levels on Treatment Outcome in People With Chronic Spinal Pain.基线恐动症水平对慢性脊柱疼痛患者治疗结果的影响。
Phys Ther. 2021 Jun 1;101(6). doi: 10.1093/ptj/pzab076.
10
Outcomes in Long-term Opioid Tapering and Buprenorphine Transition: A Retrospective Clinical Data Analysis.长期阿片类药物减量与丁丙诺啡转换的结果:一项回顾性临床数据分析
Pain Med. 2020 Dec 25;21(12):3635-3644. doi: 10.1093/pm/pnaa029.

引用本文的文献

1
Treating Anxiety-Based Cognitive Distortions Pertaining to Somatic Perception for Better Chronic Pain Outcomes: A Recommendation for Better Practice in the Present Day and the Cyber Age of Medicine.治疗与躯体感知相关的基于焦虑的认知扭曲以改善慢性疼痛结局:对当今及医学网络时代更佳实践的一项建议。
J Clin Med. 2024 Oct 4;13(19):5923. doi: 10.3390/jcm13195923.

本文引用的文献

1
Microinduction to Buprenorphine from Methadone for Chronic Pain: Outpatient Protocol with Case Examples.从美沙酮微诱导丁丙诺啡用于慢性疼痛:门诊方案及病例示例
J Pain Palliat Care Pharmacother. 2022 Mar;36(1):40-48. doi: 10.1080/15360288.2022.2049422. Epub 2022 Mar 15.
2
Prolonged cessation of chronic opioid analgesic therapy: a multidisciplinary intervention.慢性阿片类镇痛药治疗的长期停药:多学科干预。
Am J Manag Care. 2022 Feb;28(2):60-65. doi: 10.37765/ajmc.2022.88785.
3
Anxiety and Fear Avoidance Beliefs and Behavior May Be Significant Risk Factors for Chronic Opioid Analgesic Therapy Reliance for Patients with Chronic Pain-Results from a Preliminary Study.
焦虑和恐惧回避信念和行为可能是慢性阿片类镇痛药依赖的重要危险因素——一项初步研究的结果。
Pain Med. 2021 Sep 8;22(9):2106-2116. doi: 10.1093/pm/pnab069.
4
Complex Persistent Opioid Dependence with Long-term Opioids: a Gray Area That Needs Definition, Better Understanding, Treatment Guidance, and Policy Changes.伴有长期阿片类药物使用的复杂持续性阿片类药物依赖:一个需要明确界定、更好理解、治疗指导和政策改变的灰色地带。
J Gen Intern Med. 2020 Dec;35(Suppl 3):964-971. doi: 10.1007/s11606-020-06251-w. Epub 2020 Nov 6.
5
The Prescription Opioids and Depression Pathways Cohort Study.处方阿片类药物与抑郁症途径队列研究
J Psychiatr Brain Sci. 2020;5. doi: 10.20900/jpbs.20200009. Epub 2020 Apr 28.
6
Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation.美国退伍军人停止开处阿片类药物处方、接受阿片类药物治疗时间的长短与过量用药或自杀死亡之间的关联:观察性评估。
BMJ. 2020 Mar 4;368:m283. doi: 10.1136/bmj.m283.
7
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain.丁丙诺啡的叙述性药理学综述:一种用于治疗慢性疼痛的独特阿片类药物。
Pain Ther. 2020 Jun;9(1):41-54. doi: 10.1007/s40122-019-00143-6. Epub 2020 Jan 28.
8
Opioid-induced hypogonadism: Pathophysiology, clinical and therapeutics review.阿片类药物所致性腺功能减退:病理生理学、临床及治疗学综述
Clin Exp Pharmacol Physiol. 2020 May;47(5):741-750. doi: 10.1111/1440-1681.13246. Epub 2020 Jan 24.
9
Mortality After Discontinuation of Primary Care-Based Chronic Opioid Therapy for Pain: a Retrospective Cohort Study.基于初级保健的慢性阿片类药物治疗疼痛后停药的死亡率:一项回顾性队列研究。
J Gen Intern Med. 2019 Dec;34(12):2749-2755. doi: 10.1007/s11606-019-05301-2. Epub 2019 Aug 29.
10
Opioid medication discontinuation and risk of adverse opioid-related health care events.阿片类药物停药与不良阿片类药物相关医疗事件风险。
J Subst Abuse Treat. 2019 Aug;103:58-63. doi: 10.1016/j.jsat.2019.05.001. Epub 2019 May 5.